Generate a tailored SOP for Dr. Thomas Belbin. Improve your application with a focused, well-structured draft.
Thomas Belbin is an Associate Professor and GSK Research Chair in Oncology at Memorial University of Newfoundland. His research focuses on epigenetic and epigenomic regulation of gene transcription, particularly regarding head and neck squamous cell carcinoma (HNSCC). HNSCC represents a diverse array of neoplasms that can develop in various anatomical sites within the oral cavity and pharynx, presenting unique challenges based on their phenotypic behavior and histopathological characteristics. His investigations have highlighted the significance of human papillomavirus (HPV) status in tumor behavior, finding that HPV-positive HNSCCs tend to have different clinical outcomes than their HPV-negative counterparts. His work has also explored how specific molecular signatures in tumor samples can serve as prognostic markers and guide personalized treatment strategies. Through his research, Belbin aims to advance the identification of novel tumor suppressor genes and develop predictive tools that can enhance patient care in oncology.
Memorial University of Newfoundland • St. John's, NL
Teaching and research in the field of Oncology.
Albert Einstein College of Medicine • Bronx, NY
Conducted research and taught in the Department of Pathology.
Albert Einstein College of Medicine • Bronx, NY
Taught and researched in the Department of Pathology.
Albert Einstein College of Medicine • Bronx, NY
Provided instruction in pathology.
Albert Einstein College of Medicine • Bronx, NY
Conducted postdoctoral research in pathology.
Department of Business Administration (MBA program)